Categorized | Colorado News, National News, News

Drug Advertising on TV must Include Price Info

The CMS has announced a rule that requires drug manufacturers to include, in their direct-to-consumer advertising, the list price of the product being marketed.   The intent of the new ruling is to enhance transparency to consumers.  The new ruling is limited to drugs who’s list price exceeds $35 for a month’s supply.   The pricing information must be of a size and color that is easily readable and must be contained in the original ad, not referenced by a link to pricing information.

Unlike the requirement that regulates direct-to-consumer information on side effects  that is monitored by the Food and Drug Administration, this rule will be under the purview of the Centers for Medicaid and Medicare Services.

The new rule will go into effect in July and will allow drug companies to state that the actual cost may change based on the consumer’s insurance provider.

Read more in Modern Healthcare.



Contact Alexis Hertel at

(303) 322-2228

Thank You For Your Loyalty.

HCCA, publishers of the Colorado Managed Care Newsletter, began reporting on the financing of healthcare in Colorado in December of 1983. As we begin our 35th year, we are grateful for the opportunity to be one of your sources of information in this ever-changing, healthcare market.